Role of interleukin-12 in spinal cord in maintenance of arthritic pain in rats
Yalan Zhou, Haoling Li, Hui Li, Yuan-Chang Xiong, Yu‐Qiu Zhang
Abstract
Yalan Zhou, Haoling Li, Hui Li, Yuan-Chang Xiong, Yu‐Qiu Zhang
Abstract
Objective To evaluate the role of interleukin-12 (IL-12) in the spinal cord in the maintenance of arthritic pain (AP) in rats. Methods Adult male Sprague-Dawley rats, aged 6-8 weeks, weighing 200-300 g, were randomly divided into 4 groups using a random number table: control group (group C, n= 6); AP group (n= 9); phosphate buffer solution (PBS) group (n= 6); IL-12 antibody group (n= 6). AP was induced by injecting 50 μl of complete Freund's adjuvant into the ankle joint cavity of the left hindpaw of rats anesthetized with isoflurane.Goat anti-rat IL-12 antibody 1.50 μg (20 μl) was intrathecally injected on 9 days after establishment of the model in group IL-12 antibody, while 0.01 mol/L PBS (20 μl) was administered in group PBS.The mechanical paw withdrawal threshold to von Frey filament stimulation (MWT) was measured before establishment of the model (baseline) and on 9 and 10 days after establishment of the model.The rats were sacrificed after the last measurement of pain threshold, and the L4-6 segments of the spinal cord were obtained for detection of IL-12 expression in the spinal dorsal horn (by immunofluorescence), and the co-expression of IL-12 and glial fibrillary acidic protein (an astrocyte marker) was examined simultaneously in group AP. Results Compared with group C, the MWT was significantly decreased, and the expression of IL-12 was up-regulated on 9 and 10 days after establishment of the model in AP, PBS and IL-12 antibody groups.Compared with group AP, the MWT was significantly increased at 10 days after establishment of the model, and the expression of IL-12 was down-regulated in group IL-12 antibody, and no significant change was found in the MWT at 10 days after establishment of the model and expression of IL-12 in group PBS.IL-12 was co-expressed with glial fibrillary acidic protein in group AP. Conclusion IL-12 in the spinal cord is involved in the maintenance of AP in rats. Key words: Spinal cord; Interleukin-12; Arthritis; Pain
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To evaluate the role of interleukin-12 (IL-12) in the spinal cord in the maintenance of arthritic pain (AP) in rats. Methods Adult male Sprague-Dawley rats, aged 6-8 weeks, weighing 200-300 g, were randomly divided into 4 groups using a random number table: control group (group C, n= 6); AP group (n= 9); phosphate buffer solution (PBS) group (n= 6); IL-12 antibody group (n= 6). AP was induced by injecting 50 μl of complete Freund's adjuvant into the ankle joint cavity of the left hindpaw of rats anesthetized with isoflurane.Goat anti-rat IL-12 antibody 1.50 μg (20 μl) was intrathecally injected on 9 days after establishment of the model in group IL-12 antibody, while 0.01 mol/L PBS (20 μl) was administered in group PBS.The mechanical paw withdrawal threshold to von Frey filament stimulation (MWT) was measured before establishment of the model (baseline) and on 9 and 10 days after establishment of the model.The rats were sacrificed after the last measurement of pain threshold, and the L4-6 segments of the spinal cord were obtained for detection of IL-12 expression in the spinal dorsal horn (by immunofluorescence), and the co-expression of IL-12 and glial fibrillary acidic protein (an astrocyte marker) was examined simultaneously in group AP. Results Compared with group C, the MWT was significantly decreased, and the expression of IL-12 was up-regulated on 9 and 10 days after establishment of the model in AP, PBS and IL-12 antibody groups.Compared with group AP, the MWT was significantly increased at 10 days after establishment of the model, and the expression of IL-12 was down-regulated in group IL-12 antibody, and no significant change was found in the MWT at 10 days after establishment of the model and expression of IL-12 in group PBS.IL-12 was co-expressed with glial fibrillary acidic protein in group AP. Conclusion IL-12 in the spinal cord is involved in the maintenance of AP in rats. Key words: Spinal cord; Interleukin-12; Arthritis; Pain
Key concepts: Spinal cord, Medicine, Glial fibrillary acidic protein, Anesthesia, Internal medicine, Stimulation, Endocrinology, Chemistry